A study to develop a software for predicting the outcomes of febrile neutropenia (FN) in adolescent and adults with blood cancers
Not Applicable
- Conditions
- Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
- Registration Number
- CTRI/2021/11/037855
- Lead Sponsor
- Tata Memorial Hospital Research Administrative Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with leukemia, lymphoma and myeloma on chemotherapy.
2. Age more than or equal to 15 years.
3. Patients with Febrile Neutropenia
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To predict the complications in high risk FN patients complication being defined as need for intensive care admission, need for mechanical ventilation, need for vasopressor support, renal failure, arrhythmias requiring treatment, confused/altered mental state, congestive cardiac failure, bleeding requiring transfusion or death. <br/ ><br> <br/ ><br>Timepoint: This will be studied till day 28 from the day of onset of the episode
- Secondary Outcome Measures
Name Time Method The probability of isolating a drug resistant organism based on clinical, laboratory and hospital antibiogram at the baseline will be assessed.Timepoint: At the baseline;To predict the complications in low risk FN patients complication being defined as need for intensive care admission, need for mechanical ventilation, need for vasopressor support, renal failure, arrhythmias requiring treatment, confused/altered mental state, congestive cardiac failure, bleeding requiring transfusion or death.Timepoint: This will be studied till day 28 from the day of onset of the episode